Interferon-α2b/ribavirin (REBETRON®) treatment for chronic hepatitis C -: Population pharmacokinetics and pharmacodynamics of ribavirin.

被引：0
|
作者：
Glue, P [1 ]
Jen, F [1 ]
Gupta, SK [1 ]
Lau, G [1 ]
机构：
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
119
引用
收藏
页码：190A / 190A
页数：1
相关论文
共 50 条
  • [1] Interferon-α-2b and ribavirin for retreatment of chronic hepatitis C
    Dettmer, RM
    Reinus, JF
    Clain, DJ
    Aytaman, A
    Levendoglu, H
    Bloom, AA
    Isaacson, MP
    Spinnell, M
    Meyer, D
    Sarabanchong, V
    Zhang, YT
    Garcia-Carrasquillo, RJ
    Markowitz, DD
    Magun, AM
    Worman, HJ
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 758 - 763
  • [2] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [3] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [4] Rheumatic manifestations in children with chronic C virus hepatitis treated with interferon-α 2b plus ribavirin.
    Molano, A
    Gorbea, MD
    Fuentes, J
    Fraga, A
    Medina, F
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S191 - S191
  • [5] Emotional distress during interferon-α-2B and ribavirin treatment of chronic hepatitis C
    Fontana, RJ
    Schwartz, SM
    Gebremariam, A
    Lok, ASF
    Moyer, CA
    PSYCHOSOMATICS, 2002, 43 (05) : 378 - 385
  • [6] Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.
    Cornberg M.
    Wedemeyer H.
    Manns M.P.
    Current Gastroenterology Reports, 2002, 4 (1) : 23 - 30
  • [7] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [8] Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C
    Iwona Mozer-Lisewska
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 316 - 317
  • [9] Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C
    Dieperink, E
    Ho, SB
    Tetrick, L
    Thuras, P
    Dua, K
    Willenbring, ML
    GENERAL HOSPITAL PSYCHIATRY, 2004, 26 (03) : 237 - 240
  • [10] Pegylated Interferon-α2a and Ribavirin versus Pegylated Interferon-α2b and Ribavirin in Chronic Hepatitis C A Meta-Analysis
    Flori, Nicolas
    Funakoshi, Natalie
    Duny, Yohan
    Valats, Jean-Christophe
    Bismuth, Michael
    Christophorou, Dimitri
    Daures, Jean-Pierre
    Blanc, Pierre
    DRUGS, 2013, 73 (03) : 263 - 277
12345